Wegovy

Wegovy + Personalised Weight Management Plan

Clinically evident weight loss results
The prescription treatment Wegovy® uses the substance semaglutide to aid sustainable weight management. It functions similarly to the body’s own GLP-1 ‘fullness’ hormone, effectively helping to control appetite and curb hunger cues.
20.5% average weight loss (Novo Nordisk: Higher dose of Wegovy provided average weight loss of 21% in people with obesity, with a third achieving 25% or more).
Once weekly injections via a disposable pen
New pen and dosage adjustments every month
Prices: From TBA